Page 1 | Search Results | Blood | American Society of Hematology

1-18 of 18

Sort by

Sort Order Select

Journal Articles

Loss of KDM6A Confers Drug Resistance in Acute Myeloid Leukemia

Sophie M. Stief, M.Sc., Anna-Li Hanneforth, Raphael Mattes, Sabrina Weser, M.Sc., Binje Vick, PhD, Michael D. Bartoschek, M.Sc., Helena Domínguez Moreno, M.Sc., Wen-Hsin Liu, PhD, Bianka Ksienzyk, Maja Rothenberg-Thurley, PhD, Hilmar Quentmeier, PhD, Wolfgang Hiddemann, Klaus H. Metzeler, MD, Gunnar Schotta, PhD, Sebastian Bultmann, PhD, Irmela Jeremias, MD PhD, Heinrich Leonhardt, PhD, Karsten Spiekermann, MD

Blood (2018) 132 (Supplement 1): 3935.

https://doi.org/10.1182/blood-2018-99-114959

Published: 2018

Journal Articles

SLAMF7 in Primary Effusion Lymphoma, Target for Individualized Therapy?

Hilmar Quentmeier, PhD, Claudia Pommerenke, PhD, Wilhelm G Dirks, PhD, Vivien Hauer, Max Koeppel, PhD, Stefan Nagel, PhD, Michaela Scherr, PhD, Margarete Zaborski, Hans G. Drexler, MD PhD

Blood (2018) 132 (Supplement 1): 5300.

https://doi.org/10.1182/blood-2018-99-110054

Published: 2018

Journal Articles

Epigenetic Modifier Mutations in the LL-100 Panel

Hilmar Quentmeier, PhD, Claudia Pommerenke, PhD, Hans G. Drexler, MD PhD

Blood (2018) 132 (Supplement 1): 5271.

https://doi.org/10.1182/blood-2018-99-110060

Published: 2018

Journal Articles

A New Entity of Acute Myeloid Leukemia Driven By Epigenetic and Somatic Dis-Regulation of Uncx , a Novel Homeobox Transcription Factor Gene

Blood (2015) 126 (23): 1356.

https://doi.org/10.1182/blood.V126.23.1356.1356

Published: 2015

Journal Articles

FOXR1 Activation in B-Cell Lymphoma

Hilmar Quentmeier, PhD, Claudia Pommerenke, PhD, Stefan Nagel, PhD, Vivien Hauer, Margarete Zaborski, Rose Marie Amini, PhD, Mattias Berglund, PhD, Robert Geffers, PhD, Hans G Drexler, Prof. MD

Blood (2015) 126 (23): 2422.

https://doi.org/10.1182/blood.V126.23.2422.2422

Published: 2015

Journal Articles

BCL6 Overexpression – Regulated By AhR/ARNT and Wild-Type MEF2B – Drives Expression of Germinal Center Markers MYBL1 and LMO2

Hilmar Quentmeier, PhD, Jie Ding, PhD, Willy Dirks, PhD, Stefan Ehrentraut, PhD, Robert Geffers, PhD, Rod AF MacLeod, PhD, Stefan Nagel, PhD, Michaela Scherr, Lea AI Vaas, PhD, Hans G Drexler, Prof. MD

Blood (2014) 124 (21): 865.

https://doi.org/10.1182/blood.V124.21.865.865

Published: 2014

Journal Articles

Inhibition Of PI3K/mTOR Overcomes Nilotinib Resistance In BCR-ABL1 Positive Leukemia Cells

Jie Ding, PhD, Julia Romani, Margarete Zaborski, Roderick AF MacLeod, PhD, Stefan Nagel, PhD, Hans G. Drexler, MD, PhD, Hilmar Quentmeier, PhD

Blood (2013) 122 (21): 4906.

https://doi.org/10.1182/blood.V122.21.4906.4906

Published: 2013

Journal Articles

T(8;9)(p22;p24)/PCM1-JAK2 Activates SOCS2 and SOCS3 Via STAT5

Stefan Ehrentraut, Stefan Nagel, PhD, Michaela Scherr, Bjoern Schneider, Hilmar Quentmeier, PhD, Robert Geffers, PhD, Monika Prochorec-Sobieszek, Rhett P Ketterling, MD, Ryan A Knudson, Andrew L. Feldman, MD, Marshall Kadin, Hans G. Drexler, MD, PhD, Roderick AF MacLeod

Blood (2012) 120 (21): 1567.

https://doi.org/10.1182/blood.V120.21.1567.1567

Published: 2012

Journal Articles

CRLF2 and JAK2 Mutations: Occurrence and Function In Pre-B ALL Cell Lines

Hilmar Quentmeier, PhD, Sonja Eberth, PhD, Roderick AF MacLeod, PhD, Stefan Nagel, PhD, Julia Romani, Margarete Zaborski, Hans G. Drexler, MD, PhD

Blood (2010) 116 (21): 5109.

https://doi.org/10.1182/blood.V116.21.5109.5109

Published: 2010

Journal Articles

Induction of Apoptosis In Imatinib-Resistant BCR-ABL1 -Positive Leukemia Cell Lines by Bortezomib

Hilmar Quentmeier, PhD, Sonja Eberth, PhD, Julia Romani, Margarete Zaborski, Hans G. Drexler, MD, PhD

Blood (2010) 116 (21): 4469.

https://doi.org/10.1182/blood.V116.21.4469.4469

Published: 2010

Journal Articles

Methylation Status of Tumor Suppressor Genes BEX2, IGSF4, RARB and TIMP3 Is Indicative for AML with Translocations of the MLL Gene.

Hilmar Quentmeier, PhD, Willy G. Dirks, PhD, Stefan Nagel, PhD, Sonja Röhrs, PhD, Björn Schneider, PhD, Hans G. Drexler, PhD

Blood (2007) 110 (11): 2115.

https://doi.org/10.1182/blood.V110.11.2115.2115

Published: 2007

Journal Articles

Comprehensive Analysis of Homeobox Genes in Hodgkin Lymphoma Cell Lines Identified Dysregulated Expression of HOXB9 Mediated by Constitutive Active ERK5 Signalling Pathway and BMI1.

Stefan Nagel, PhD, Cristof Burek, PhD, Letizia Venturini, PhD, Michaela Scherr, PhD, Hilmar Quentmeier, PhD, Corinna Meier, Andreas Rosenwald, MD, Hans G. Drexler, MD, Roderick A.F. MacLeod, PhD

Blood (2006) 108 (11): 471.

https://doi.org/10.1182/blood.V108.11.471.471

Published: 2006

Journal Articles

Analysis of MLL Amplification and 5q Deletions in AML/MDS Cell Lines Identifies Novel Targets.

Bjoern Schneider, Stefan Nagel, PhD, Maren Kaufmann, Hilmar Quentmeier, PhD, Yoshinobu Matsuo, PhD, Hans G. Drexler, MD, Roderick A.F. MacLeod, PhD

Blood (2006) 108 (11): 1424.

https://doi.org/10.1182/blood.V108.11.1424.1424

Published: 2006

Journal Articles

JAK2 V617F Tyrosine Kinase Mutation in Leukemia Cell Lines.

Hilmar Quentmeier, PhD, Roderick A.F. MacLeod, PhD, Julia Reinhardt, Margarete Zaborski, Hans G. Drexler, PhD

Blood (2005) 106 (11): 4505.

https://doi.org/10.1182/blood.V106.11.4505.4505

Published: 2005

Journal Articles

Exon-12 Nucleophosmin ( NPM ) Mutation and Aberrant Cytoplasmic Expression of NPM Protein in Leukemia Cell Line OCI-AML3.

Hilmar Quentmeier, PhD, Maria P. Martelli, PhD, Wilhelm G. Dirks, PhD, Niccolo Bolli, PhD, Arcangelo Liso, PhD, Roderick A.F. MacLeod, PhD, Ildo Nicoletti, PhD, Roberta Mannucci, PhD, Alessandra Pucciarini, PhD, Barbara Bigerna, PhD, Massimo F. Martelli, PhD, Cristina Mecucci, PhD, Hans G. Drexler, MD, PhD, Brunangelo Falini, PhD

Blood (2005) 106 (11): 2376.

https://doi.org/10.1182/blood.V106.11.2376.2376

Published: 2005

Journal Articles

Guide to Leukemia-Lymphoma Cell Lines on CD.

Hans G. Drexler, MD, PhD, Roderick A.F. MacLeod, PhD, Stefan Nagel, PhD, Willy G. Dirks, PhD, Cord C. Uphoff, PhD, Klaus G. Steube, PhD, Hilmar Quentmeier, PhD

Blood (2005) 106 (11): 4340.

https://doi.org/10.1182/blood.V106.11.4340.4340

Published: 2005

Journal Articles

MHH-TALL1, a T-ALL Cell Line Expressing a Novel BCR-ABL Transcript.

Hilmar Quentmeier, PhD, Jan Cools, PhD, Roderick A.F. MacLeod, PhD, Peter Marynen, PhD, Cord C. Uphoff, PhD, Hans G. Drexler, MD, PhD

Blood (2004) 104 (11): 4390.

https://doi.org/10.1182/blood.V104.11.4390.4390

Published: 2004

Journal Articles

BEX1 , a Marker for Acute Myeloid Leukemia Cell Lines with MLL Rearrangements.

Hilmar Quentmeier, PhD, Wilhelm G. Dirks, PhD, Robert Geffers, PhD, Cord C. Uphoff, PhD, Hans G. Drexler, MD, PhD

Blood (2004) 104 (11): 3013.

https://doi.org/10.1182/blood.V104.11.3013.3013

Published: 2004

NARROW

Loss of KDM6A Confers Drug Resistance in Acute Myeloid Leukemia

SLAMF7 in Primary Effusion Lymphoma, Target for Individualized Therapy?

Epigenetic Modifier Mutations in the LL-100 Panel

A New Entity of Acute Myeloid Leukemia Driven By Epigenetic and Somatic Dis-Regulation of Uncx , a Novel Homeobox Transcription Factor Gene

FOXR1 Activation in B-Cell Lymphoma

BCL6 Overexpression – Regulated By AhR/ARNT and Wild-Type MEF2B – Drives Expression of Germinal Center Markers MYBL1 and LMO2

Inhibition Of PI3K/mTOR Overcomes Nilotinib Resistance In BCR-ABL1 Positive Leukemia Cells

T(8;9)(p22;p24)/PCM1-JAK2 Activates SOCS2 and SOCS3 Via STAT5

CRLF2 and JAK2 Mutations: Occurrence and Function In Pre-B ALL Cell Lines

Induction of Apoptosis In Imatinib-Resistant BCR-ABL1 -Positive Leukemia Cell Lines by Bortezomib

Methylation Status of Tumor Suppressor Genes BEX2, IGSF4, RARB and TIMP3 Is Indicative for AML with Translocations of the MLL Gene.

Comprehensive Analysis of Homeobox Genes in Hodgkin Lymphoma Cell Lines Identified Dysregulated Expression of HOXB9 Mediated by Constitutive Active ERK5 Signalling Pathway and BMI1.

Analysis of MLL Amplification and 5q Deletions in AML/MDS Cell Lines Identifies Novel Targets.

JAK2 V617F Tyrosine Kinase Mutation in Leukemia Cell Lines.

Exon-12 Nucleophosmin ( NPM ) Mutation and Aberrant Cytoplasmic Expression of NPM Protein in Leukemia Cell Line OCI-AML3.

Guide to Leukemia-Lymphoma Cell Lines on CD.

MHH-TALL1, a T-ALL Cell Line Expressing a Novel BCR-ABL Transcript.

BEX1 , a Marker for Acute Myeloid Leukemia Cell Lines with MLL Rearrangements.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only